+91-8455-699999
Corporate Brochure
|
Fosun Pharma
Home
(current)
About Us
Our Capabilities
API Facilities
Formulation Facilities
R&D
Our Business
Business Model
India Business
Therapeutic Coverage
Investors
FINANCIALS
SUBSIDIARY FINANCIALS
ANNUAL REPORTS
ANNUAL RETURN
PRESENTATIONS
SHAREHOLDER'S INFORMATION
STOCK EXCHANGE ANNOUNCEMENTS
CORPORATE GOVERNANCE
DISCLOSURES UNDER REGULATION 46 SEBI(LODR)
INVESTORS CONTACT
Resources
NEWS
CSR
Contact Us
Search
Home
About Us
Our Capabilities
API Facilities
Formulation Facilities
R&D
OUR BUSINESS
Business Model
India Business
Therapeutic Coverage
INVESTORS
FINANCIALS
SUBSIDIARY FINANCIALS
ANNUAL REPORTS
ANNUAL RETURN
PRESENTATIONS
SHAREHOLDER'S INFORMATION
STOCK EXCHANGE ANNOUNCEMENTS
CORPORATE GOVERNANCE
DISCLOSURES UNDER REGULATION 46 SEBI(LODR)
INVESTORS CONTACT
Resources
NEWS
CSR
Contact Us
Home
Investors
Shareholder Information
Gland Pharma Shareholder Information
Stock Information
BSE
View Details
NSE
View Details
Shareholding Pattern
Shareholding Pattern as on June 30, 2023.
Open file
Shareholding Pattern as on March 31, 2023.
Open file
Shareholding Pattern as on December 31, 2022.
Open file
Shareholding Pattern as on September 30, 2022
Open file
Shareholding Pattern as on June 30, 2022
Open file
Shareholding Pattern as on March 31, 2022
Open file
Shareholding Pattern as on December 31, 2021
Open file
Shareholding Pattern as on September 30, 2021
Open file
Shareholding Pattern as on March 31, 2021
Open file
Shareholding Pattern as on December 31, 2020
Open file
Shareholding Pattern as on listing date
Open file
Shareholding Pattern as on 30th June 2021
Open file
Annual Secretarial Compliance Report
Annual Secretarial Compliance Report for FY 2022-23
Open file
Annual Secretarial Compliance Report for FY 2021-22
Open file
Annual Secretarial Compliance Report for FY 2020-21
Open file
General Meetings
Memorandum & Articles of Association
Open file
Monitoring Agency Report
Statement of Deviation or Variation for Q2FY23.
Open file
Statement of Deviation or Variation for Q1FY23
Open file
Monitoring Agency Report Q4FY22
Open file
Monitoring Agency Report Q3FY22
Open file
Monitoring Agency Report Q2FY22
Open file
Monitoring agency report Q1FY22
Open file
Monitoring Agency Report-Q4FY21
Open file
Monitoring Agency Report - Q3 FY21
Open file
Grievance Redressal
E-mail:
investors@glandpharma.com
Postal Ballot - 2022
Postal Ballot Notice - 2022
Open file
Voting Result of Postal Ballot
Open file
Postal Ballot - 2023
Postal Ballot Notice - 2023
Open file
Voting Results of Postal Ballot 2023
Open file
Scrutinizer’s Report on Postal Ballot with UDIN
Open file
